1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow XMAB-2513: new trials by email Literature Review of XMAB-2513 trials Research Report on XMAB-2513
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma XmAb2513 - Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Xencor, Inc. | 23 | 2007-12-01 | 2014-04-21 |
Hodgkin Disease (1) · Lymphoma, Large-Cell, Anaplastic (1)
Xencor, Inc. (1)
United States (1)
Anas Younes, MD (1)